Connection

Carol Sherman to Clinical Trials, Phase II as Topic

Back to Details
This is a "connection" page, showing publications Carol Sherman has written about Clinical Trials, Phase II as Topic.
Carol Sherman
Connection Strength
0.011
Clinical Trials, Phase II as Topic
  1. Advances in treatment of inoperable NSCLC: gemcitabine doublets--a promising alternative. Oncology (Williston Park). 2000 Jul; 14(7 Suppl 4):7-14.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.